陳肇始:首劑接種率目標9成 達到或推疫苗通行證 調整社交措施
食物及衛生局局長陳肇始表示,政府將第一劑新冠疫苗接種率90%訂爲目標,只要向90%目標邁進,當局將考慮以「疫苗通行證」爲基礎,視乎疫情發展調整多項社交距離措施。
她在網址中提及,新冠疫苗接種計劃於去年2月底展開以來,截至昨日(29日),約530萬名市民已接種首劑疫苗,佔合資格人口約79%;80歲以上長者的接種率超過3成,相對偏低。
陳肇始稱,當局將擴大「主動評估 ─ 接種」計劃,希望儘快爲超過1,000間安老院及殘疾人士院舍院友接種疫苗;計劃下,當院友獲確認適合接種疫苗,而家屬無明確反對,到診註冊醫生或醫療機構取得院友或法定監護人知情同意下爲院友接種科興疫苗。(me/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.